• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Apolipoprotein E Gene in α-Synucleinopathies: A Narrative Review.载脂蛋白 E 基因在 α-突触核蛋白病中的作用:叙事性综述。
Int J Mol Sci. 2024 Feb 1;25(3):1795. doi: 10.3390/ijms25031795.
2
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.路易体痴呆与帕金森病痴呆:当前的概念和争议。
J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8.
3
Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease.路易体病和阿尔茨海默病的脑淀粉样血管病的患病率、分布和严重程度不同。
Acta Neuropathol Commun. 2024 Feb 15;12(1):28. doi: 10.1186/s40478-023-01714-7.
4
Dementia with Lewy bodies.路易体痴呆
Semin Clin Neuropsychiatry. 2003 Jan;8(1):46-57. doi: 10.1053/scnp.2003.50006.
5
Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?路易体痴呆和帕金森病痴呆是同一种疾病吗?
BMC Med. 2018 Mar 6;16(1):34. doi: 10.1186/s12916-018-1016-8.
6
Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies.帕金森病痴呆死后脑组织中病理标志物的表达增加,与路易体痴呆相比。
BMC Neurosci. 2022 Jan 4;23(1):3. doi: 10.1186/s12868-021-00687-4.
7
The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia.老年患者轻度至中度路易体痴呆中老年综合征的存在和巧合。
BMC Neurol. 2022 Sep 19;22(1):355. doi: 10.1186/s12883-022-02897-7.
8
Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.路易体痴呆与帕金森病痴呆的新临床病理特征有别。
Neuropathol Appl Neurobiol. 2021 Feb;47(1):143-156. doi: 10.1111/nan.12648. Epub 2020 Aug 12.
9
Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.载脂蛋白 E2、E3 和 E4 通过不同信号通路在人神经元中介导阿尔茨海默病风险。
J Neurosci. 2019 Sep 11;39(37):7408-7427. doi: 10.1523/JNEUROSCI.2994-18.2019. Epub 2019 Jul 22.
10
[Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].帕金森病痴呆与路易体痴呆的病理及临床比较
Orv Hetil. 2020 May 1;161(18):727-737. doi: 10.1556/650.2020.31715.

引用本文的文献

1
APOE genetic variability in an Egyptian cohort of PD.埃及帕金森病队列中的APOE基因变异性
Front Neurosci. 2025 May 23;19:1579968. doi: 10.3389/fnins.2025.1579968. eCollection 2025.
2
Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis.多系统萎缩患者脑脊液和血液中的神经丝轻链:一项系统评价和荟萃分析
Brain Sci. 2025 Feb 25;15(3):241. doi: 10.3390/brainsci15030241.
3
Spectrum and Prevalence of Rare Variants and Their Association with Familial Dysbetalipoproteinemia.罕见变异的谱系、患病率及其与家族性异常β脂蛋白血症的关联
Int J Mol Sci. 2024 Nov 25;25(23):12651. doi: 10.3390/ijms252312651.
4
More evidence for widespread antagonistic pleiotropy in polymorphic disease alleles.多态性疾病等位基因中广泛存在拮抗性多效性的更多证据。
Front Genet. 2024 Jun 17;15:1404516. doi: 10.3389/fgene.2024.1404516. eCollection 2024.

本文引用的文献

1
The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review.鞘脂类物质在阿尔茨海默病不同发病机制中的作用:全面综述。
Biomed Pharmacother. 2024 Feb;171:116071. doi: 10.1016/j.biopha.2023.116071. Epub 2024 Jan 6.
2
Molecular modeling of apoE in complexes with Alzheimer's amyloid-β fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids.apoE 与人脑阿尔茨海默病淀粉样β纤维复合物的分子建模表明载脂蛋白与淀粉样蛋白共沉积的结构基础。
Cell Mol Life Sci. 2023 Nov 27;80(12):376. doi: 10.1007/s00018-023-05026-w.
3
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches.阿尔茨海默病:蛋白质在发病机制、作用机制和新治疗方法中的作用。
Neurosci Lett. 2023 Nov 20;817:137532. doi: 10.1016/j.neulet.2023.137532. Epub 2023 Oct 20.
4
Apolipoprotein E genotype-dependent accumulation of amyloid β in APP-knock-in mouse model of Alzheimer's disease.载脂蛋白 E 基因型依赖性淀粉样 β 在阿尔茨海默病 APP 敲入小鼠模型中的积累。
Biochem Biophys Res Commun. 2023 Nov 26;683:149106. doi: 10.1016/j.bbrc.2023.10.038. Epub 2023 Oct 10.
5
APOE-ε4 and BIN1 increase risk of Alzheimer's disease pathology but not specifically of Lewy body pathology.载脂蛋白 E-ε4 和 BIN1 增加了阿尔茨海默病病理的风险,但并非特异性增加路易体病理的风险。
Acta Neuropathol Commun. 2023 Sep 12;11(1):149. doi: 10.1186/s40478-023-01626-6.
6
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease.早发性帕金森病中 APOE 基因型的临床和神经化学相关性。
Neurobiol Aging. 2023 Nov;131:24-28. doi: 10.1016/j.neurobiolaging.2023.07.011. Epub 2023 Jul 20.
7
Neuronal ApoE4 in Alzheimer's disease and potential therapeutic targets.阿尔茨海默病中的神经元载脂蛋白E4及潜在治疗靶点。
Front Aging Neurosci. 2023 Jun 2;15:1199434. doi: 10.3389/fnagi.2023.1199434. eCollection 2023.
8
Multiple system atrophy - a clinicopathological update.多系统萎缩——临床病理新进展
Free Neuropathol. 2020 Jul 3;1:17. doi: 10.17879/freeneuropathology-2020-2813. eCollection 2020 Jan.
9
Gait and balance in apolipoprotein Ɛ4 allele carriers in older adults and Parkinson's disease.老年人和帕金森病中载脂蛋白Ɛ4等位基因携带者的步态与平衡
Clin Park Relat Disord. 2023 May 17;9:100201. doi: 10.1016/j.prdoa.2023.100201. eCollection 2023.
10
APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson's disease.在患有帕金森病的尼日利亚人中,APOE E4与自我报告的认知障碍相关,但与疾病风险或发病年龄无关。
NPJ Parkinsons Dis. 2022 Nov 12;8(1):155. doi: 10.1038/s41531-022-00411-x.

载脂蛋白 E 基因在 α-突触核蛋白病中的作用:叙事性综述。

Apolipoprotein E Gene in α-Synucleinopathies: A Narrative Review.

机构信息

Department of Neurology, University Hospital of Larissa, School of Medicine, University of Thessaly, 41100 Larissa, Greece.

Department of Neurology, University Hospital of Patras, School of Medicine, University of Patras, 26504 Rio Patras, Greece.

出版信息

Int J Mol Sci. 2024 Feb 1;25(3):1795. doi: 10.3390/ijms25031795.

DOI:10.3390/ijms25031795
PMID:38339074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10855384/
Abstract

In this narrative review, we delved into the intricate interplay between alleles (typically associated with Alzheimer's disease-AD) and alpha-synucleinopathies (aS-pathies), involving Parkinson's disease (PD), Parkinson's disease dementia (PDD), dementia with Lewy bodies (DLB), and multiple-system atrophy (MSA). First, in-vitro, animal, and human-based data on the exacerbating effect of on LB pathology were summarized. We found robust evidence that carriage constitutes a risk factor for PDD-APOE2, and APOE3 may not alter the risk of developing PDD. We confirmed that copies confer an increased hazard towards DLB, as well. Again and appear unrelated to the risk of conversion. Of note, in individuals with DLB , carriage appears to be intermediately prevalent between AD and PDD-PD (AD > DLB > PDD > PD). Less consistency existed when it came to PD; -PD associations tended to be markedly modified by ethnicity. Finally, we failed to establish an association between the gene and MSA. Phenotypic associations (age of disease onset, survival, cognitive-neuropsychiatric- motor-, and sleep-related manifestations) between alleles, and each of the aforementioned conditions were also outlined. Finally, a synopsis of literature gaps was provided followed by suggestions for future research.

摘要

在这篇叙述性评论中,我们深入探讨了等位基因(通常与阿尔茨海默病相关)与α-突触核蛋白病(aS-病)之间的复杂相互作用,涉及帕金森病(PD)、帕金森病痴呆(PDD)、路易体痴呆(DLB)和多系统萎缩(MSA)。首先,我们总结了关于 对 LB 病理学加剧作用的体外、动物和基于人体的数据。我们发现了强有力的证据表明 携带构成 PDD-APOE2 的风险因素,而 APOE3 可能不会改变发生 PDD 的风险。我们还证实了 拷贝数增加了 DLB 的发病风险。同样, 和 似乎与转换风险无关。值得注意的是,在患有 DLB 的个体中, 携带的比例在 AD 和 PDD-PD(AD > DLB > PDD > PD)之间似乎处于中间水平。当涉及到 PD 时,一致性较低;-PD 关联往往因种族而明显改变。最后,我们未能确定 基因与 MSA 之间存在关联。还概述了等位基因与上述每种情况之间的表型关联(疾病发病年龄、存活、认知-神经心理学-运动-和睡眠相关表现)。最后,提供了文献差距的概要,并提出了未来研究的建议。